A successful management with electroconvulsive therapy of neuroleptic malignant syndrome due to amisulpride

被引:0
|
作者
Karayagmurlu, Ali [1 ]
Karayagmurlu, Elif [2 ]
Ustundag, Mehmet Fatih [3 ]
Yazla, Ece [4 ]
机构
[1] Gaziantep Child State Hosp, Dept Child & Adolescent Psychiat, Gaziantep, Turkey
[2] Gaziantep Univ, Dept Psychiat, Fac Med, Gaziantep, Turkey
[3] Erenkoy Training & Res Hosp Psychiat & Neurol Dis, Dept Psychiat, Istanbul, Turkey
[4] Hitit Univ, Fac Med, Dept Psychiat, Corum, Turkey
来源
ELECTRONIC JOURNAL OF GENERAL MEDICINE | 2018年 / 15卷 / 03期
关键词
amisulpride; atypical antipsychotics; neuroleptic malignant syndrome; electroconvulsive therapy;
D O I
10.29333/ejgm/83617
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Neuroleptic malignant syndrome is a severe complication that mainly occurs based on neuroleptic drug treatment and characterized with some autonomic symptoms, altered mental state, hyperthermia and muscle rigidity. Amisulpride is a unique atypical antipsychotic that selectively blocks D2 and D3 receptors presynaptically in the frontal cortex and atypical antipsychotics are rarely caused neuroleptic malignant syndrome (NMS). This study examine a 20-years old male with the diagnosis of acute psychotic disorder occurred amisulpride-induced NMS and successfully treated with Electroconvulsive Therapy (ECT). We decided to present that case because of the fact that there is only limited number of amisulpride-induced NMS cases reported in the literature.
引用
收藏
页数:4
相关论文
共 50 条
  • [41] Successful management of delirium with dexmedetomidine in a patient with haloperidol-induced neuroleptic malignant syndrome: A case report
    Yang, Chi-Ju
    Chiu, Ching-Tang
    Yeh, Yu-Chang
    Chao, Anne
    WORLD JOURNAL OF CLINICAL CASES, 2022, 10 (02) : 625 - 630
  • [42] Anesthetic management of a pediatric patient with neuroleptic malignant syndrome
    Tarun Bhalla
    Douglas Maxey
    Amod Sawardekar
    Joseph D. Tobias
    Journal of Anesthesia, 2012, 26 : 250 - 253
  • [43] Anesthetic management of a pediatric patient with neuroleptic malignant syndrome
    Bhalla, Tarun
    Maxey, Douglas
    Sawardekar, Amod
    Tobias, Joseph D.
    JOURNAL OF ANESTHESIA, 2012, 26 (02) : 250 - 253
  • [44] Neuroleptic malignant syndrome and atypical antipsychotics: A brief review
    Khaldi, S.
    Kornreich, C.
    Choubani, Z.
    Gourevitch, R.
    ENCEPHALE-REVUE DE PSYCHIATRIE CLINIQUE BIOLOGIQUE ET THERAPEUTIQUE, 2008, 34 (06): : 618 - 624
  • [45] Neuroleptic malignant syndrome following cardiac surgery: successful treatment with dantrolene
    Mieno, S
    Asada, K
    Horimoto, H
    Sasaki, S
    EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2003, 24 (03) : 458 - 460
  • [46] Neuroleptic malignant syndrome
    Knorr, R.
    Schoellkopf, J.
    Haen, E.
    NERVENARZT, 2018, 89 (03): : 300 - 310
  • [47] Neuroleptic Malignant Syndrome
    N. Ravishankar
    The Indian Journal of Pediatrics, 2016, 83 : 732 - 733
  • [48] LETHAL CATATONIA AND THE NEUROLEPTIC MALIGNANT SYNDROME
    ANDERSON, WH
    CRITICAL CARE MEDICINE, 1991, 19 (11) : 1333 - 1334
  • [49] Neuroleptic malignant syndrome: a guide for psychiatrists
    Wadoo, Ovais
    Ouanes, Sami
    Firdosi, Mudasir
    BJPSYCH ADVANCES, 2021, 27 (06) : 373 - 382
  • [50] Neuroleptic Malignant Syndrome
    Ravishankar, N.
    INDIAN JOURNAL OF PEDIATRICS, 2016, 83 (07) : 732 - 733